Richard M. W. Hoetelmans

Author

Also Known As

David Nauwelaers, Hoetelmans, R. M. W., R HOETELMANS, R Hoetelmans, R M Hoetelmans, R M W Hoetelmans, R. M. W. Hoetelmans, R.M.W. Hoetelmans, Richard Hoetelmans, Richard M Hoetelmans

154

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

Slotervaartziekenhuis University of Amsterdam Janssen (Belgium)Amsterdam UMC Location University of Amsterdam Radboud University Nijmegen

About

Richard M. W. Hoetelmans is an author at Slotervaartziekenhuis specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	46	2.2K
2	Health Sciences	4	4	88
3	Engineering	2	2	90
4	Biochemistry	2	2	93
5	Social Sciences	1	1	31

Richard M. W. Hoetelmans

104

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals Agnes I. Veldkamp, Gerrit Jan Weverling, Joep M. A. Lange, AIDS	2001	207
Drug interaction between St John's wort and nevirapine Monique M. R. de Maat, Richard M. W. Hoetelmans, Ron A. A. Mathôt, AIDS ImmunologyCytochrome P450 SystemPharmacotherapyAntiviral DrugOxidative Stress	2001	177
Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine Norbert A. Foudraine, Richard M. W. Hoetelmans, Joep MA Lange, The Lancet Drug ConcentrationsMedicineHuman RetrovirusAntiviral Drug DevelopmentAntiviral Therapy	1998	172
P-Glycoprotein Limits Oral Availability, Brain, and Fetal Penetration of Saquinavir Even with High Doses of Ritonavir Maarten T. Huisman, Johan W. Smit, Hugh Wiltshire, Molecular Pharmacology	2001	166
Low Plasma Concentrations of Indinavir are Related to Virological Treatment Failure in HIV-1-Infected Patients on Indinavir-Containing Triple Therapy David M. Burger, Richard M. W. Hoetelmans, Patricia W. H. Hugen, Antiviral Therapy Virological Treatment FailureTreatment And PreventionIndinavir-containing Triple TherapyLow Plasma ConcentrationsIndinavir Plasma Concentrations	1998	161
The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals Rolf P. G. van Heeswijk, Agnes I. Veldkamp, Jan W. Mulder, AIDS	2000	133
The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy Richard M. W. Hoetelmans, Monique H. Reijers, Gerrit Jan Weverling, AIDS	1998	130
Short-term antiviral activity of TMC278 – a novel NNRTI – in treatment-naive HIV-1-infected subjects F. D. Goebel, Alexy Yakovlev, Anton Pozniak, AIDS	2006	129
Darunavir: Pharmacokinetics and Drug Interactions David Back, Vanitha Sekar, Richard M. W. Hoetelmans Antiviral Therapy Darunavir InhibitsImmunologyPharmacotherapyAntiviral DrugDrug Resistance	2008	122
Efficacy of Cerebrospinal Fluid (CSF)–Penetrating Antiretroviral Drugs against HIV in the Neurological Compartment: Different Patterns of Phenotypic Resistance in CSF and Plasma Andrea Antinori, Carlo Federico Perno, Maria Letizia Giancola, Clinical Infectious Diseases	2005	113

Page 1